Overview
Kim De Lange practices practicing medicine in Groningen, Netherlands.
Their clinical expertise encompasses Leukemia, Renal Cell Carcinoma (RCC), and Lung Metastases.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kim De Lange
Is Kim De Lange a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Kim De Lange is classified as an Experienced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kim De Lange participate in research or clinical trials?
Yes. Kim De Lange has published 9 articles and abstracts on conditions like Leukemia. You can view a list of Kim De Lange's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- LeukemiaDe Lange isExperienced. Learn about Leukemia.
- Lung MetastasesDe Lange isExperienced. Learn about Lung Metastases.
- Renal Cell Carcinoma (RCC)De Lange isExperienced. Learn about Renal Cell Carcinoma (RCC).